News & Events

Bio-Rad Acquires GnuBIO, Developer of Droplet-Based DNA Sequencing Technology

April 11, 2014 08:41 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–GnuBIO, a privately-held life sciences company that has developed a droplet-based DNA sequencing technology, today announced that it was …continue reading…

GnuBIO Initiates Formation of its Clinical Advisory Panel

GnuBIO has initiated the formation of its Clinical Advisory Panel, composed of luminaries and experts in clinical diagnostics, bolstering its efforts in standardized assay content development   Cambridge, Massachusetts …continue reading…

GnuBIO to Present at Cowen and Company 33rd Annual Health Care Conference

President and CEO, John Boyce to present “Sequencing for the Clinic: Sample In,  Answer Out in 3.5 Hours”, at Cowen and Company 33rd Annual Health Care Conference. Cambridge, Massachusetts …continue reading…

GnuBIO Unveils the World’s First Prototype Fully Integrated DNA Sequencer at the Association of Molecular Pathology Conference

Cambridge, Massachusetts – (October 24, 2012) – GnuBIO, Inc. (GnuBIO), www.gnubio.com a pioneer in the Desktop DNA sequencing market, announced today that it will unveil the prototype of the …continue reading…

GnuBIO Secures $10 Million in Series B Financing

Along With Grant from the NHGRI of $4.5MM GnuBIO Plans to Expand Product Offering to Whole Genome Sequencing Cambridge, MA–(Oct 4, 2012) – GnuBIO, today announced that it has completed …continue reading…